BioSpace News Archive

Biotech Beach

DCISionRT® Demonstrates 40 Percent Change in Radiation Therapy Treatment Recommendation for DCIS Patients

Prelude Corporation announced today it will be presenting new data on its ongoing prospective PREDICT study of DCIS patients at the 2021 San Antonio Breast Cancer Symposium (SABCS), being held on December 7 – 10 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.

December 2, 2021
·
5 min read
FDA

Chemomab Announces FDA Clearance of Its IND Application for CM-101, a First-In-Class CCL24 Neutralizing Antibody for the Treatment of Primary Sclerosing Cholangitis

Chemomab Therapeutics, Ltd. today announced that the U.S. Food and Drug Administration (“FDA”) has cleared the company’s Investigational New Drug (“IND”) application for CM-101, a first-in-class CCL24-neutralizing antibody for the treatment of the rare disease primary sclerosing cholangitis (PSC).

December 2, 2021
·
6 min read
Bio NC

RedHill Biopharma Data Published in GastroHep Shows Consistent Efficacy of Talicia Irrespective of Patient BMI

RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, announces the publication of a new study entitled “Helicobacter pylori Eradication by Low-Dose Rifabutin Triple Therapy,

December 2, 2021
·
13 min read
CollPlant Announces Publication Highlighting its rhCollagen-based Photocurable Dermal Filler in the Plastic and Reconstructive Surgery Journal

CollPlant Biotechnologies today announced the publication of an article in the Plastic and Reconstructive Surgery journal.

December 2, 2021
·
6 min read
Pharm Country

BrainStorm Cell Therapeutics to Present New Biomarker Data on NurOwn® at the International Symposium on ALS/MND

BrainStorm Cell Therapeutics Inc. today announced that biomarker data on NurOwn® will be presented at the 32nd International Symposium on ALS/MND, to be held virtually 7-10 December 2021.

December 2, 2021
·
7 min read
Drug Development

Karyopharm Completes Patient Recruitment in Phase 3 SIENDO Study of Selinexor in Patients with Endometrial Cancer

Karyopharm Therapeutics Inc. today announced the completion of patient recruitment in the Phase 3 SIENDO study evaluating the efficacy and safety for front-line maintenance therapy with selinexor in patients with advanced or recurrent endometrial cancer.

December 2, 2021
·
13 min read
Genetown

Boston Scientific Initiates Trial to Evaluate Industry’s First Modular CRM System

Boston Scientific Corporation (NYSE: BSX) has initiated the MODULAR ATP clinical trial to evaluate the safety, performance and effectiveness of the mCRM™ Modular Therapy System.

December 2, 2021
·
6 min read
Genetown

iSpecimen Expands Supplier Network of Human Biospecimens to Help Advance Research in Neurological Disorders

iSpecimen Inc. today announced it has recently expanded its global biospecimen provider network in support of research related to neurological disorders, which afflict around one billion people worldwide, or an estimated 1 in 6 people (UN).

December 2, 2021
·
4 min read
Business

ELNA Medical Builds on its Ambitious Growth Strategy with Two Additional Key Executives

ELNA Medical is pleased to announce two additional key management appointments to support and accelerate its growth strategy across Canada.

December 2, 2021
·
2 min read
Biotech Beach

Tryp Therapeutics Receives Confirmation from FDA to Proceed with Phase 2a Study in Fibromyalgia

Tryp Therapeutics announced today that it has received confirmation from the U.S. Food and Drug Administration (" FDA ") that its review of Tryp’s Investigational New Drug (“IND”) application is complete and that the Company may proceed with its clinical study in fibromyalgia.

December 2, 2021
·
4 min read